BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mak M, Lam C, Pineda SJ, Lou M, Xu LY, Meeks C, Lin C, Stone R, Rodgers K, Mitani G. Pharmacogenetics of Warfarin in a Diverse Patient Population. J Cardiovasc Pharmacol Ther 2019;24:521-33. [PMID: 31064211 DOI: 10.1177/1074248419843530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Avilés-Santa ML, Hsu L, Lam TK, Arteaga SS, Artiles L, Coady S, Cooper LS, Curry J, Desvigne-Nickens P, Nicastro HL, Rosario A. Funding of Hispanic/Latino Health-Related Research by the National Institutes of Health: An Analysis of the Portfolio of Research Program Grants on Six Health Topic Areas. Front Public Health 2020;8:330. [PMID: 33014952 DOI: 10.3389/fpubh.2020.00330] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Haga SB. Pharmacogenomic Testing In Pediatrics: Navigating The Ethical, Social, And Legal Challenges. Pharmgenomics Pers Med 2019;12:273-85. [PMID: 31686893 DOI: 10.2147/PGPM.S179172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Barbarawi M, Zayed Y, Kheiri B, Gakhal I, Barbarawi O, Bala A, Alabdouh A, Abdalla A, Rizk F, Bachuwa G, Katato K. The role of anticoagulation in venous thromboembolism primary prophylaxis in patients with malignancy: A systematic review and meta-analysis of randomized controlled trials. Thromb Res 2019;181:36-45. [PMID: 31349093 DOI: 10.1016/j.thromres.2019.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Alghamdi MA, Al-Eitan L, Alkhatib R, Al-Assi A, Almasri A, Aljamal H, Aman H, Khasawneh R. Variants in CDHR3, CACNAC1, and LTA Genes Predisposing Sensitivity and Response to Warfarin in Patients with Cardiovascular Disease. Int J Gen Med 2021;14:1093-100. [PMID: 33790638 DOI: 10.2147/IJGM.S298597] [Reference Citation Analysis]
5 Chen H, Dai DP, Zhou S, Liu J, Wang SH, Wu HL, Zhou Q, Geng PW, Chong J, Lü Y, Cai JP, Yang JF. An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62. Chem Biol Interact 2020;327:109168. [PMID: 32531309 DOI: 10.1016/j.cbi.2020.109168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Iba T, Connors JM, Spyropoulos AC, Wada H, Levy JH. Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered? Int J Hematol 2021;113:330-6. [PMID: 33471294 DOI: 10.1007/s12185-021-03078-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Shah RR. Genotype‐guided warfarin therapy: Still of only questionable value two decades on. J Clin Pharm Ther 2020;45:547-60. [DOI: 10.1111/jcpt.13127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]